Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus™ spacer for inhalation

Clinical Pharmacokinetics

Volumn 45, Issue 7, 2006, Pages 729-736

  Drollmann, Anton ^a   Nave, Ruediger ^a   Steinijans, Volker W ^a   Baumgärtner, Eugen ^b   Bethke, Thomas D ^a  

^a ALTANA PHARMA AG   (Germany)

^b IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; DESISOBUTYRYL CICLESONIDE; DRUG METABOLITE; FLUORINATED HYDROCARBON; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHALATION SPACER; MALE; METERED DOSE INHALER; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANTI-ASTHMATIC AGENTS; AREA UNDER CURVE; ASTHMA; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PREGNENEDIONES;

EID: 33745599325     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200645070-00007     Document Type: Article

References (29)

1. Georgitis JW. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. Chest 1999 Jan; 115 (1): 210-7
2. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999 May; 159 (9): 941-55
3. Jackson LD, Polygenis D, McIvor RA, et al. Comparative efficacy and safety of inhaled corticosteroids in asthma. Can J Clin Pharmacol 1999 Spring; 6 (1): 26-37
4. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998 Dec; 12 (6): 1346-53
5. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999 Sep; 83 (3): 153-79
6. Konig P. Spacer devices used with metered-dose inhalers: breakthrough or gimmick? Chest 1985 Aug; 88 (2): 276-84
7. 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med 2006; 100 (3): 375-84
8. Mutch E, Nave R, Zech K, et al. Esterases involved in the hydrolysis of ciclesonide in human tissues [abstract]. Eur Respir J 2003; 22 (45 Suppl.) 1749
9. Nave R, Fisher R, Zech K. In vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm Drug Dispos 2006; 27 (4): 197-207
10. Ukena D, Biberger C, von Behren V, et al. Ciclesonide significantly improves pulmonary function when compared with budesonide: a randomized 12-week study [abstract no. P2640]. Eur Respir J 2003 Sep; 22 Suppl. 45: 411s
11. Buhl R, Vinkler I, Magyar P, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther. 2005 Nov 23, [Epub ahead of print]
12. Lipworth BJ, Kaliner MA, LaForce CF, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005 Apr; 94 (4): 465-72
13. Derom E, Van De Velde V, Marissens S, et al. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5′monophosphate in asthmatic patients. Pulm Pharmacol Ther 2005; 18 (5): 328-36
14. Nave R, Zech K, Bethke TD. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. Eur J Clin Pharmacol 2005 May; 61 (3): 203-8
15. European Pharmacopoeia, 5th edition online. Section 2.9.18 Preparations for inhalations: aerodynamic assessment of fine particles 04-2005: 20918; Apparatus D - Andersen Cascade Impactor [online]. Available from URL: http://online.pheur.org [Accessed 2005 Jun 23]
16. Spacers and holding chambers for use with metered-dose inhalers [standard]. Publication Z264.1-02. Mississauga (ON): Canadian Standards Association, 2002 Oct
17. Sauter R, Steinijans VW, Diletti E, et al. Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1992 Jul; 30 (7): 233-56
18. Chapman KR, Patel P, D'Urzo AD, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2005; 60 (3): 330-7
19. Postma DS, Sevette C, Martinat Y, et al. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 2001 Jun; 17: 1083-8
20. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004 Apr; 309 (1): 249-58
21. Nave R, Bethke TD, van Marle SP, et al. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet 2004; 43 (7): 479-86
22. Peet CF, Enos T, Nave R, et al. Identification of enzymes involved in phase I metabolism of ciclesonide by human liver microsomes. Eur J Drug Metab Pharmacokinet 2005 Oct-Dec; 30 (4): 275-86
23. Leach CL, Bethke TD, Boudreau RJ, et al. 2-D and 3-D imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers. J Aerosol Med. In press.
24. Leach CL, Davidson PJ, Hasselquist BE, et al. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002 Aug; 122 (2): 510-6
25. Pickering H, Pitcairn GR, Hirst PH, et al. Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler. Clin Ther 2000 Dec; 22 (12): 1483-93
26. Thorsson L, Edsbacker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994 Oct; 7 (10): 1839-44
27. Nelson HS, Loffert DT. Comparison of the bronchodilator response to albuterol administered by the OptiHaler, the AeroChamber, or by metered dose inhaler alone. Ann Allergy 1994 Apr; 72 (4): 337-40
28. Cheng NG, Browne GJ, Lam LT, et al. Spacer compliance after discharge following a mild to moderate asthma attack. Arch Dis Child 2002 Oct; 87 (4): 302-5
29. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986 Feb; 41 (2): 118-24